受体
细胞因子
机制(生物学)
免疫学
炎症
生物标志物
医学
生物
内科学
遗传学
哲学
认识论
作者
Jianjing Shang,Yuxin Xu,Sheng‐Dan Pu,Xiaotong Sun,Xin‐Yuan Gao
出处
期刊:Cytokine
[Elsevier]
日期:2023-11-01
卷期号:171: 156348-156348
被引量:2
标识
DOI:10.1016/j.cyto.2023.156348
摘要
In recent years, IL-34 has been widely discussed as a novel cytokine. IL-34 is a pro-inflammatory cytokine binding four distinct receptors, namely CSF-1R, syndecan-1, PTP-ζ and TREM2. Previous studies have shown that IL-34 and its receptors play important roles in the development and progression of various inflammatory diseases. Therefore, IL-34 has the potential to be a biomarker and therapeutic target for inflammatory diseases. However, further study is still needed to identify the specific mechanism through which IL-34 contributes to illness. In this article, we review the recent advances in the biological roles of IL-34 and its receptors as well as their roles in the development and therapeutic application of inflammatory diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI